Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma

Alison, 2005, Liver cancer: The role of stem cells, Cell Prolif., 38, 407, 10.1111/j.1365-2184.2005.00354.x Bandsma, 2001, Acute inhibition of glucose-6-phosphate translocator activity leads to increased de novo lipogenesis and development of hepatic steatosis without affecting VLDL production in rats, Diabetes, 50, 2591, 10.2337/diabetes.50.11.2591 Beg, 1995, Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB, Nature, 376, 167, 10.1038/376167a0 Bentires-Alj, 2001, Inhibition of the NF-κB transcription factor increases Bax expression in cancer cell lines, Oncogene, 20, 2805, 10.1038/sj.onc.1204343 Brunt, 2004, Nonalcoholic steatohepatitis, Semin. Liver Dis., 24, 3, 10.1055/s-2004-823098 Burke, 2003, Targeting IκB kinase for the treatment of inflammatory and other disorders, Curr. Opin. Drug Discov. Devel., 6, 720 Canbay, 2005, The relationship between apoptosis and non-alcoholic fatty liver disease: An evolutionary cornerstone turned pathogenic, Z. Gastroenterol., 43, 211, 10.1055/s-2004-813744 Chaisson, 2002, Hepatocyte-specific inhibition of NF-κB leads to apoptosis after TNF treatment, but not after partial hepatectomy, J. Clin. Invest., 110, 193, 10.1172/JCI0215295 Coffinier, 2002, Bile system morphogenesis defects and liver dysfunction upon targeted deletion of HNF1β, Development, 129, 1829, 10.1242/dev.129.8.1829 Coleman, 1993, Interaction of incontinentia pigmenti and factor VIII mutations in a female with biased X inactivation, resulting in haemophilia, J. Med. Genet., 30, 497, 10.1136/jmg.30.6.497 Courtois, 2005, The NF-κB signaling pathway in human genetic diseases, Cell. Mol. Life Sci., 62, 1682, 10.1007/s00018-005-5031-5 Enomoto, 2002, Thalidomide prevents alcoholic liver injury in rats through suppression of Kupffer cell sensitization and TNF-α production, Gastroenterology, 123, 291, 10.1053/gast.2002.34161 Fang, 2004, Function of oval cells in hepatocellular carcinoma in rats, World J. Gastroenterol., 10, 2482, 10.3748/wjg.v10.i17.2482 Farrell, 2006, Nonalcoholic fatty liver disease: From steatosis to cirrhosis, Hepatology, 43, S99, 10.1002/hep.20973 Festjens, 2004, Bcl-2 family members as sentinels of cellular integrity and role of mitochondrial intermembrane space proteins in apoptotic cell death, Acta Haematol., 111, 7, 10.1159/000074483 Gao, 2000, N-terminal cleavage of bax by calpain generates a potent proapoptotic 18-kDa fragment that promotes bcl-2-independent cytochrome C release and apoptotic cell death, J. Cell. Biochem., 80, 53, 10.1002/1097-4644(20010101)80:1<53::AID-JCB60>3.0.CO;2-E Ghosh, 2002, Missing pieces in the NF-κB puzzle, Cell, 109, S81, 10.1016/S0092-8674(02)00703-1 Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9 Herling, 1999, Alterations of carbohydrate and lipid intermediary metabolism during inhibition of glucose-6-phosphatase in rats, Eur. J. Pharmacol., 386, 75, 10.1016/S0014-2999(99)00748-7 1995, Terminology of nodular hepatocellular lesions, Hepatology, 22, 983, 10.1002/hep.1840220341 Karin, 1999, How NF-κB is activated: The role of the IκB kinase (IKK) complex, Oncogene, 18, 6867, 10.1038/sj.onc.1203219 Karin, 2002, NF-κB at the crossroads of life and death, Nat. Immunol., 3, 221, 10.1038/ni0302-221 Kellendonk, 2000, Hepatocyte-specific expression of Cre recombinase, Genesis, 26, 151, 10.1002/(SICI)1526-968X(200002)26:2<151::AID-GENE17>3.0.CO;2-E Kojiro, 2005, Early hepatocellular carcinoma and dysplastic nodules, Semin. Liver Dis., 25, 133, 10.1055/s-2005-871193 Lavon, 2000, High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-κB activation, Nat. Med., 6, 573, 10.1038/75057 Lee, 2006, A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells, Nat. Med., 12, 410, 10.1038/nm1377 Li, 1999, Severe liver degeneration in mice lacking the IκB kinase 2 gene, Science, 284, 321, 10.1126/science.284.5412.321 Li, 1999, The IKKβ subunit of IκB kinase (IKK) is essential for nuclear factor κB activation and prevention of apoptosis, J. Exp. Med., 189, 1839, 10.1084/jem.189.11.1839 Libbrecht, 2001, Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis, Histopathology, 39, 66, 10.1046/j.1365-2559.2001.01172.x Libbrecht, 2005, Preneoplastic lesions in human hepatocarcinogenesis, Liver Int., 25, 16, 10.1111/j.1478-3231.2005.01016.x Luedde, 2005, Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury, J. Clin. Invest., 115, 849, 10.1172/JCI23493 Luedde, 2002, Losing balance: Cytokine signaling and cell death in the context of hepatocyte injury and hepatic failure, Eur. Cytokine Netw., 13, 377 Maeda, 2003, IKKβ is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFα, Immunity, 19, 725, 10.1016/S1074-7613(03)00301-7 Maeda, 2005, IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis, Cell, 121, 977, 10.1016/j.cell.2005.04.014 Makris, 2000, Female mice heterozygous for IKKγ/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti, Mol. Cell, 5, 969, 10.1016/S1097-2765(00)80262-2 Marshall, 2005, Relation between hepatocyte G1 arrest, impaired hepatic regeneration, and fibrosis in chronic hepatitis C virus infection, Gastroenterology, 128, 33, 10.1053/j.gastro.2004.09.076 Motola-Kuba, 2006, Hepatocellular carcinoma. An overview, Ann. Hepatol., 5, 16, 10.1016/S1665-2681(19)32034-4 Nenci, 2006, Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling, Hum. Mol. Genet., 15, 531, 10.1093/hmg/ddi470 Oberti, 1997, [Association of hepatic adenomatosis and hepatoportal sclerosis in a woman with incontinentia pigmenti], Gastroenterol. Clin. Biol., 21, 147 Okuda, 2000, Hepatocellular carcinoma, J. Hepatol., 32, 225, 10.1016/S0168-8278(00)80428-6 Pahl, 1999, Activators and target genes of Rel/NF-κB transcription factors, Oncogene, 18, 6853, 10.1038/sj.onc.1203239 Pasparakis, 1996, Immune and inflammatory responses in TNFα-deficient mice: A critical requirement for TNFα in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response, J. Exp. Med., 184, 1397, 10.1084/jem.184.4.1397 Pasparakis, 2002, TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2, Nature, 417, 861, 10.1038/nature00820 Pfeffer, 1993, Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection, Cell, 73, 457, 10.1016/0092-8674(93)90134-C Pikarsky, 2004, NF-κB functions as a tumour promoter in inflammation-associated cancer, Nature, 431, 461, 10.1038/nature02924 Ramadori, 2001, Cytokines in the liver, Eur. J. Gastroenterol. Hepatol., 13, 777, 10.1097/00042737-200107000-00004 Rudolph, 2000, Severe liver degeneration and lack of NF-κB activation in NEMO/IKKγ-deficient mice, Genes Dev., 14, 854, 10.1101/gad.14.7.854 Schmidt-Supprian, 2000, NEMO/IKKγ-deficient mice model incontinentia pigmenti, Mol. Cell, 5, 981, 10.1016/S1097-2765(00)80263-4 Schwabe, 2006, Mechanisms of liver injury. I. TNF-α-induced liver injury: Role of IKK, JNK, and ROS pathways, Am. J. Physiol. Gastrointest. Liver Physiol., 290, G583, 10.1152/ajpgi.00422.2005 Sherman, 2005, Hepatocellular carcinoma: Epidemiology, risk factors, and screening, Semin. Liver Dis., 25, 143, 10.1055/s-2005-871194 Strasser, 1999, FADD/MORT1, a signal transducer that can promote cell death or cell growth, Int. J. Biochem. Cell Biol., 31, 533, 10.1016/S1357-2725(99)00003-5 Tamura, 2003, Bax cleavage implicates caspase-dependent H2O2-induced apoptosis of hepatocytes, Int. J. Mol. Med., 11, 369 Tanaka, 1999, Embryonic lethality, liver degeneration, and impaired NF-κB activation in IKK-β-deficient mice, Immunity, 10, 421, 10.1016/S1074-7613(00)80042-4